Agilent Technologies Quick Ratio 2010-2024 | A
Historical quick ratio values for Agilent Technologies (A) over the last 10 years.
| Agilent Technologies Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2024-07-31 |
$3.28B |
$2.39B |
1.37 |
| 2024-04-30 |
$3.20B |
$1.96B |
1.64 |
| 2024-01-31 |
$3.31B |
$1.62B |
2.04 |
| 2023-10-31 |
$3.16B |
$1.60B |
1.97 |
| 2023-07-31 |
$2.96B |
$1.76B |
1.68 |
| 2023-04-30 |
$2.85B |
$1.67B |
1.71 |
| 2023-01-31 |
$2.97B |
$1.94B |
1.53 |
| 2022-10-31 |
$2.74B |
$1.86B |
1.47 |
| 2022-07-31 |
$2.68B |
$1.90B |
1.41 |
| 2022-04-30 |
$2.71B |
$1.81B |
1.49 |
| 2022-01-31 |
$2.60B |
$1.58B |
1.64 |
| 2021-10-31 |
$2.97B |
$1.71B |
1.74 |
| 2021-07-31 |
$2.81B |
$1.72B |
1.63 |
| 2021-04-30 |
$2.72B |
$1.76B |
1.55 |
| 2021-01-31 |
$2.73B |
$1.69B |
1.62 |
| 2020-10-31 |
$2.70B |
$1.47B |
1.84 |
| 2020-07-31 |
$2.50B |
$1.31B |
1.90 |
| 2020-04-30 |
$2.42B |
$1.95B |
1.25 |
| 2020-01-31 |
$2.40B |
$1.89B |
1.27 |
| 2019-10-31 |
$2.51B |
$2.08B |
1.21 |
| 2019-07-31 |
$2.80B |
$1.62B |
1.72 |
| 2019-04-30 |
$3.16B |
$1.12B |
2.82 |
| 2019-01-31 |
$3.06B |
$1.10B |
2.79 |
| 2018-10-31 |
$3.21B |
$1.17B |
2.74 |
| 2018-07-31 |
$3.04B |
$1.01B |
3.00 |
| 2018-04-30 |
$3.93B |
$1.37B |
2.88 |
| 2018-01-31 |
$3.79B |
$1.36B |
2.78 |
| 2017-10-31 |
$3.59B |
$1.26B |
2.85 |
| 2017-07-31 |
$3.43B |
$1.24B |
2.76 |
| 2017-04-30 |
$3.25B |
$1.19B |
2.74 |
| 2017-01-31 |
$3.08B |
$1.09B |
2.83 |
| 2016-10-31 |
$3.10B |
$0.95B |
3.28 |
| 2016-07-31 |
$2.99B |
$1.15B |
2.60 |
| 2016-04-30 |
$2.93B |
$1.13B |
2.59 |
| 2016-01-31 |
$2.85B |
$0.95B |
3.00 |
| 2015-10-31 |
$3.15B |
$0.98B |
3.22 |
| 2015-07-31 |
$2.93B |
$0.85B |
3.44 |
| 2015-04-30 |
$3.06B |
$0.93B |
3.30 |
| 2015-01-31 |
$3.09B |
$0.93B |
3.33 |
| 2014-10-31 |
$4.94B |
$1.69B |
2.92 |
| 2014-07-31 |
$3.74B |
$1.58B |
2.37 |
| 2014-04-30 |
$4.28B |
$1.72B |
2.49 |
| 2014-01-31 |
$3.99B |
$1.55B |
2.57 |
| 2013-10-31 |
$3.92B |
$1.60B |
2.45 |
| 2013-07-31 |
$3.53B |
$1.55B |
2.28 |
| 2013-04-30 |
$3.78B |
$1.91B |
1.98 |
| 2013-01-31 |
$3.67B |
$1.85B |
1.99 |
| 2012-10-31 |
$3.62B |
$1.89B |
1.91 |
| 2012-07-31 |
$3.18B |
$2.09B |
1.52 |
| 2012-04-30 |
$5.06B |
$1.84B |
2.76 |
| 2012-01-31 |
$4.78B |
$1.71B |
2.80 |
| 2011-10-31 |
$4.67B |
$1.84B |
2.54 |
| 2011-07-31 |
$4.33B |
$1.51B |
2.87 |
| 2011-04-30 |
$4.24B |
$1.59B |
2.67 |
| 2011-01-31 |
$3.80B |
$1.41B |
2.70 |
| 2010-10-31 |
$5.45B |
$3.08B |
1.77 |
| 2010-07-31 |
$5.05B |
$2.92B |
1.73 |
| 2010-04-30 |
$5.17B |
$2.71B |
1.91 |
| 2010-01-31 |
$4.97B |
$2.55B |
1.95 |
| 2009-10-31 |
$3.41B |
$1.12B |
3.04 |
| 2009-07-31 |
$2.33B |
$0.99B |
2.35 |
| 2009-04-30 |
$2.28B |
$1.10B |
2.07 |
| 2009-01-31 |
$2.35B |
$1.13B |
2.08 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Electrical Test Equipment |
$38.462B |
$6.833B |
|
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|
